Status:

COMPLETED

Monitoring Exhaled Propofol to Individualize General Anesthesia

Lead Sponsor:

University of California, San Francisco

Conditions:

General Anesthesia

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

This trial investigates the relationship between concentrations of the anesthetic drug propofol in exhaled breath, blood and drug effect in volunteers undergoing general anesthesia. The main goal of t...

Eligibility Criteria

Inclusion

  • 18 years of age
  • Written informed consent
  • Ability and willingness to give written informed consent
  • American Society of Anesthesiologists (ASA) risk score I

Exclusion

  • Volunteers ASA physical status II - III
  • Pregnancy
  • Volunteers with history of neurological disease or stroke
  • Volunteers with a history of recreational drug abuse
  • Volunteers with a history of alcohol abuse
  • Smokers
  • Anesthesia within 6 months
  • Known drug allergies
  • History of adverse events during general anesthesia

Key Trial Info

Start Date :

August 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2010

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT01191021

Start Date

August 1 2010

End Date

October 1 2010

Last Update

June 5 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Anesthesia and Perioperative Care, UCSF

San Francisco, California, United States, 94122

Monitoring Exhaled Propofol to Individualize General Anesthesia | DecenTrialz